Navigation Links
US Supreme Court Denies Certiorari and Thereby Leaves in Place Second Circuit Ruling That Novartis Pharmaceuticals Corporation Must Pay its Sales Representatives Overtime Compensation
Date:2/28/2011

WASHINGTON, Feb. 28, 2011 /PRNewswire/ -- The U.S. Supreme Court today denied Novartis Pharmaceuticals Corporation's petition for certiorari, thereby refusing to disturb the liability judgment against Novartis issued by the Second Circuit in In re Novartis Wage & Hour Litigation, 611 F.3d 141 (2010). The Second Circuit held that thousands of U.S. sales representatives ("Reps") employed by Novartis are entitled to overtime pay because the Reps are not subject to either the "Outside Sales" or "Administrative" exemptions to overtime compensation under Federal, New York and California law.

In so ruling, the Second Circuit gave controlling deference to the opinion of the U.S. Secretary of Labor, who filed an amicus brief supporting the position that two exclusions to overtime pay – the Outside Sales and Administrative exemptions – did not apply to Novartis's Reps.

"The Court's denial of certiorari to Novartis is a victory for thousands of the company's Reps who labored long and hard for Novartis – often working over 70 hours a week – and yet were denied the overtime pay that is their due," said David Sanford, founding partner in Sanford Wittels & Heisler, LLP ("SWH"), the law firm representing the Novartis Reps.  "Everybody knows that justice delayed is justice denied.  We are hopeful that Novartis will do the right thing and carry out the Second Circuit's ruling by immediately instituting an overtime compensation system for its Reps and paying the Reps the overtime monies that the company has withheld for so many years."

Another SWH partner, Jeremy Heisler, pointed out that New York state recently amended its overtime laws and, effective April 11, 2011, an employer who fails to pay its employees required overtime compensation is subject to increased penalties.  "We are sure Novartis is aware of this development and will act accordingly to bring the Novartis overtime litigation to a just and expeditious resolution."

SWH serves as Lead or co-Lead Counsel for four new and nearly identical wage and hour class action suits now pending against other pharmaceutical companies by their U.S. sales representatives, including suits against Pfizer, Roche, Merck and Abbott Laboratories. SWH also recently secured the largest jury award in the U.S. in an employment discrimination case in May 2010 when a jury returned a verdict of $253 million in compensatory and punitive damage against Novartis Pharmaceuticals Corporation.  Novartis subsequently settled that case for $175 million.

About SWH

Sanford Wittels & Heisler LLP (SWH) is a law firm with offices in Washington, D.C., New York, and San Francisco that specializes in employment discrimination, wage and hour, consumer and complex corporate class action litigation and has represented thousands of individuals in some of the major class action cases in the United States. The firm also represents individual clients in employment, employment discrimination, sexual harassment, whistleblower, public accommodations, commercial, medical malpractice, and personal injury matters.


'/>"/>
SOURCE Sanford Wittels & Heisler LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Supreme Court of Israel Rules in Favor of Sun Pharma
2. Pfizer Reigns Supreme After Patent Cliff as Humira Kicks Avastin off Top Spot
3. Montana Supreme Court Decision Endangers Most Vulnerable Citizens
4. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
5. Court of Appeals Overturns $1.8 Billion Patent Verdict for Centocor Ortho Biotech Inc.
6. Final Superior Court Ruling on Trade Secret Lawsuit Favors Volcano Corporation and Its Axsun Subsidiary
7. Watson Announces Favorable District Court Ruling in Generic Mucinex® Patent Suit
8. Massachusetts Court Rules in Favor of Volcano and Against St. Jude Medical Subsidiary in Trade Secrets Case
9. Sensipar® Patents Upheld By District Court
10. U.S. District Court Rules from Bench in Lillys Favor, Confirms Validity of Alimta Patent
11. Occlutech Wins Dutch Appeal Court Ruling Against AGA Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... YORK , April 28, 2016  While ... notably complement the company,s valve repair and stent ... move also places Abbott more firmly into patient ... of the fastest growing device areas, with double-digit ... its recent report,  Advanced Remote Patient Monitoring ...
(Date:4/28/2016)... YORK , April 28, 2016  The blood ... 275 million dollars, according to Kalorama Information and The ... typing, immunoassays and nucleic acid testing.  The healthcare research ... made progress in developing blood collection stations and in ... made in Kalorama Information,s report, Blood Testing ...
(Date:4/28/2016)... , April 28, 2016 Oramed ... a clinical-stage pharmaceutical company focused on the development of oral ... in the upcoming PIONEERS 2016 conference, presented by Joseph ... 2016 in New York . Nadav ... at the conference. Presentation Details:   ...
Breaking Medicine Technology:
(Date:4/29/2016)... Sterling, VA (PRWEB) , ... April 29, 2016 ... ... Americans with student loans more flexibility in repaying their loans, more information about ... at a time when total outstanding student loan debt, including federal and private ...
(Date:4/29/2016)... ... April 29, 2016 , ... A ... born with severe congenital diaphragmatic hernia have better survival rates if surgery is ... hernia (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs ...
(Date:4/29/2016)... ... ... Mobility Designed is redefining mobility with their patent pending crutch design. ... distributes body weight from the elbow to the forearm. In consumer tests, users ... other crutches. , Co-founders Max and Liliana Younger were inspired to design the crutches ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... Melanoma is the deadliest type of skin ... blame for the majority of skin cancer deaths. More than 10,000 people are expected to ... at diagnosis is 62, it is the one of the most commonly diagnosed cancers in ...
(Date:4/29/2016)... Hills, CA (PRWEB) , ... April 29, 2016 , ... ... of devices and products for the head and neck/ear, nose and throat specialty, has ... Device , The KOTLER NASAL AIRWAY™ is a newly patented safety device ...
Breaking Medicine News(10 mins):